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Those more experienced with EVR were more likely to use
EVR. 30-day mortality was lower for EVR overall and for
each quintile (p0.01). The advantage ranged from 2.4%
in Q5 to 4.0% in Q1. 5 year survival was improved for EVR
for Q1-Q3 (p0.01) and equivalent for Q4 and Q5. Both
30 day mortality and conversion rates decreased monoton-
ically from Q1 to Q5 (p0.01), with mortality ranging
from 1.5% to 2.4% and conversion rates from 1.4 to 6.4%.
Conclusions: Using likelihood to receive surgery as a
proxy for clinical judgment, clinical outcomes are better for
patients who receive EVR in all groups. These data suggest
both that clinical judgment is related to outcomes, and that
EVR may offer advantage to some patients who don’t
receive it.
Author Disclosures: N. Egorova: Nothing to disclose;
L. C. Kleinman: Nothing to disclose; J. F. McKinsey:
Nothing to disclose; A. Moskowitz: Nothing to disclose.
PS36.
Severe Proximal Aneurysm Neck Angulation: Mid-
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Objectives: Proximal neck anatomy is considered a
major limiting factor for EVAR. However, advances in
stentgraft technology may have overcome previous bound-
aries. We aim to investigate the influence of severe proximal
neck angulation on mid-term outcome when using the
Endurant Stentgraft System.
Methods: Analysis of a prospective multicenter data-
base identified 45 elective patients (mean age 74, 86%
males) with severe angulation of the proximal neck (75
degrees infra-renal or 60 degrees supra-renal), all treated
with the Endurant stentgraft. Mean angles were 80.8 de-
grees (SD:15.6) infra-renal and 51.4 degrees (SD:21.1)
supra-renal. These were compared to a matched control
group without significant angulation. Mean follow-up was
18 months (5.3), with all patients having at least 1-year
surveillance. The primary endpoint was freedom from an-
eurysm-related complications. Secundary end-points were
overall survival, re-intervention rate, and aneurysm sac be-
haviour. Post-processing using 3D reconstruction software
was used for all patients. Student’s t-test, Pearson’s chi-
squared and Kaplan-Maier analysis were used when
appropriate.
Results: Survival was similar in both groups (p0.84)
as was freedom from AAA-related complications (p0.70).
Only one patient suffered from AAA rupture, and that was
on the non-angulated group. At 1-year 65% of patients in
the angulated group showed shrinkage of the aneurysm sac,
compared to 60.4% in the non-angulated group (p0.78),
while sac increase was noted in 3.1% and 6.5%, respectively
(p0.54). No type-I endoleaks, migrations or stent frac-
tures were noted in either group. At 1-year infra-renal neck
neck angulation (degrees) changed to 6321 degrees.
Conclusions: Proximal neck angulation had no signif-
icant influence on the early and mid-term results after
EVAR when using the Endurant stentgraft. Little changes
can be expected in the underlying anatomy during follow-
up, confirming the compliant nature of the device.
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Objectives: The percent of total abdominal aortic an-
eurysm (AAA) repairs performed by endovascular aneu-
rysm repair (EVAR) increased rapidly from 32% in 2001 to
65% in 2006 with considerable variation between states.
We hypothesized that hospitals in competitive markets
were early EVAR adopters and had improved AAA repair
outcomes. We tested this hypothesis using the Nationwide
Inpatient Sample (NIS) database and linked Hospital Mar-
ket Structure (HMS) files published by theHealthcare Cost
and Utilization Project (HCUP).
Methods: 2003 NIS and HMS data was queried for
patients who underwent repair for non-ruptured AAA. In
HMS theHerfindahl Hirschman Index (HHI, range 0-1) is a
validated and widely accepted economic measure of competi-
tion. Hospital markets were defined using a variable geo-
graphic radius that encompassed 90% of discharged patients.
We conducted bivariate and multivariate logistic regression
analyses for the dependent variable of EVARuse. A propensity
score-adjusted multivariate logistic regression model was
used to control for treatment bias in the assessment of
competition on AAA-repair outcomes.
Results: A weighted total of 23,542 patients was in-
cluded in our analyses. Patients at more competitive hospi-
tals (lower HHI) were at increased odds of undergoing
EVAR vs. open repair (Odds Ratio 1.127 per 0.1 decrease
inHHI, P0.0127) after adjusting for patient demograph-
ics, co-morbidities and hospital level factors (bedsize,
teaching status, AAA repair volume and ownership). Com-
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petition was not associated with differences in in-hospital
mortality or vascular, neurologic or other minor post-
operative complications.
Conclusions: Greater hospital competition is signifi-
cantly associated with increased EVAR adoption at a time
when diffusion of this technology passed its tipping point.
Hospital competition does not influence post-AAA repair
outcomes. These results suggest that adoption of novel
vascular technology is not solely driven by clinical indica-
tions, but may also be influenced by market forces.
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Objectives: One of the major limitations to endovas-
cular treatment of the thoracic aorta is inadequate landing
zone (LZ), thrombus or heavy calcification within the LZ.
Debranching of the aortic arch vessels has been used as a
solution with good results. Stenting of the supra-aortic
branches, the “snorkel” technique, has been described with
immediate good results but the short to intermediate term
outcomes are not well described.
Methods: Between January 2008 and December
2009, 16 TEVARs were performed using the “snorkel”
technique for the supra-aortic branches. The indication for
using this technique was inadequate LZ, and thrombus
within the LZ. The charts were retrospectively reviewed
and the patients were followed in the aortic disease clinic.
Results: The mean age of the patients was 62 years
(range 46-84). There were 6 (38%) females and 10 (62%)
males. The pathologies included aneurysms, chronic type B
dissections, and traumatic aortic transections. One (6.3%)
snorkel was placed in the innominate artery, 4 (25%) in the
left common carotid artery (CCA), and 11 (69%) in the left
subclavian artery (SCA). The mean follow-up period is 14
months (range 3-28 months). There was one (6%) death
unrelated to the procedure. There were no instances of
stroke or paralysis. There were no stent fractures. One
(6.3%) stent became occluded a week after implantation
and needed to be revised. There was one case of persistent
type Ia endoleak.
Conclusions: Placement of endoluminal grafts beyond
zone 2 is a more challenging and complicated procedure.
These cases require meticulous planning and careful man-
agement of the supra-aortic branches. Our short-term re-
sults support the use of this technique in appropriately
selected cases, to extend the LZ beyond zone 2. Long term
results are pending.
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Objectives: Reports of the superiority of endovascular
repair (EVAR) for ruptured abdominal aortic aneurysm
(rAAA) suffer from selection bias and limited FU. This
study is a single center propensity score comparison of early
and midterm outcomes between open repair (OR) and
EVAR.
Methods: Retrospective review from 1/2001-11/
2010 identified 312 pts who underwent rAAA repairs. 31
with prior AAA repair and 3 with incomplete records were
excluded, leaving 37 EVARs and 241 ORs. Propensity
score-based matching for sex, age, preoperative hemody-
namic status, surgeon’s annual AAA volume and comor-
bidities was performed in 1:3 ratio to compare outcomes.
37 EVARs were matched with 111 ORs. Late survival was
estimated by KM curves.
Results: Operative time and blood replacement were
higher with OR. Operative mortality was similar (22.2%
EVAR vs 34.3% OR) with an odds ratio of 0.56 for EVAR
(95% CI[0.22, 1.30], P0.18). Overall complication
rates were similar (54.3% EVAR vs 68.0% OR), except for
more tracheostomies with OR (22.9% OR vs 2.9% EVAR,
p0.018). KM estimates of 1, 2 and 3 year survival rates
were similar (48%, 48%, 38.4% EVAR vs 56.4%, 38.8%,
28.2% OR).
Conclusions: EVAR for rAAA does not seem to con-
clusively confer either acute or late survival benefits.
EVAR
(n37)
OR
(n111) P
Age (years) 75 76 0.6
Male (%) 70.3 68.5 0.99
Operative time (min) 138.8 209.2 0.0001
Packed Red Blood Cells 3.1 7.4 0.0002
Fresh Frozen Plasma 0.6 3.9 0.002
Platelet 0.3 o.8 0.02
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